Cargando…
Immune-mediated vincristine-induced neuropathy: Unlocking therapies
Vincristine-induced peripheral neuropathy (VIPN) is a prevalent and painful complication in cancer patients that lacks effective treatments. In this issue of JEM, Starobova et al. (2021. J. Exp. Med. https://doi.org/10.1084/jem.20201452) report that VIPN is driven by innate immune system activation,...
Autores principales: | Savelieff, Masha G., Feldman, Eva L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992412/ https://www.ncbi.nlm.nih.gov/pubmed/33751022 http://dx.doi.org/10.1084/jem.20210286 |
Ejemplares similares
-
Four keys to unlock IgG
por: Nimmerjahn, Falk, et al.
Publicado: (2021) -
FRC-derived retinoic acid: The key to unlocking milky spots
por: Daley, Alexander D., et al.
Publicado: (2023) -
Vincristine-Induced Cranial Neuropathy
por: TALEBIAN, Ahmad, et al.
Publicado: (2014) -
Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model
por: Elzinga, Sarah E., et al.
Publicado: (2021) -
Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)